ACTRN12614000722695已完成不适用
Comparison of the effects of two oral contraceptive pills (OCPs) containing either chlormadinone acetate or drospirenone as the progestogen,on metabolic and hormonal parameters in women with polycystic ovary syndrome (PCOS) for a period of two years follow-up
Recep Yildizhan0 个研究点目标入组 106 人开始时间: 2014年7月8日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 106
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 35 Years（—）
- 性别
- Female
入选标准
- •Polycystic ovary syndrome
排除标准
- •The subjects took no medications (oral contraceptives, glucocorticoids, antiandrogens, insulin sensitizers, ovulation induction agents, or antiobesity drugs) that could affect the biochemical profile and metabolic variables for at least 6 months before entering the study. The exclusion criteria included Cushing’s syndrome, congenital adrenal hyperplasia, hyperprolactinemia, thyroid dysfunction, virilizing tumors, glucose intolerence or diabetes mellitus, hepatic dysfunction, renal dysfunction, hypertension and any contraindications for the use of combined oral contraceptives.
研究者
相似试验
尚未招募
Unknown
To compare the effects of two drugs in the management of abnormal uterine bleedingCTRI/2024/07/070066Government Medical College and Hospital Sector Chandigarh India Pincode
尚未招募
4 期
ew treatments for troublesome bleeding in Implanon usersnacceptable bleeding pattern in women using the progestogen-only sub-dermal contraceptive implantUnacceptable bleeding pattern in women using the progestogen-only sub-dermal contraceptive implantReproductive Health and Childbirth - ContraceptionACTRN12611000617965Dr Edith Weisberg200
已完成
2 期
Comparing the effect of Oral Contraceptive LD and Vitex to treat Polycystic ovarian syndromepolycystic ovarian syndrome.Sclerocystic ovary syndrome Stein-Leventhal syndromeIRCT201306116709N13Research deputy of Tabriz University of Medical Sciences80
已完成
3 期
Comparison of combined oral contraceptive Yasmin and Cyproteron compound on Hirsutism and androgens in women with a polycystic ovary syndromeCondition 1: Polycystic ovarian syndrome. Condition 2: Hirsutism.Polycystic ovarian syndromeHypertrichosisIRCT201104251760N13Vice Chancellor for Research and Technology, Babol University of Medical Sciences100
尚未招募
4 期
To compare efficacy and safety of oral contraceptive pill vs pioglitazone in polycystic ovary syndrome (PCOS) women.CTRI/2020/03/024267SKIMS